J Yeungnam Med Sci.  2022 Apr;39(2):81-88. 10.12701/yujm.2021.01228.

Current diagnosis and treatment of vestibular neuritis: a narrative review

• Bae CH
• Na HG
• Choi YS

• KMID: 2529265
• DOI: http://doi.org/10.12701/yujm.2021.01228

Abstract

Vertigo is the sensation of self-motion of the head or body when no self-motion is occurring or the sensation of distorted self-motion during an otherwise normal head movement. Representative peripheral vertigo disorders include benign paroxysmal positional vertigo, Ménière disease, and vestibular neuritis. Vestibular neuritis, also known as vestibular neuronitis, is the third most common peripheral vestibular disorder after benign paroxysmal positional vertigo and Ménière disease. The cause of vestibular neuritis remains unclear. However, a viral infection of the vestibular nerve or ischemia of the anterior vestibular artery is known to cause vestibular neuritis. In addition, recent studies on immune-mediated mechanisms as the cause of vestibular neuritis have been reported. The characteristic clinical features of vestibular neuritis are abrupt true-whirling vertigo lasting for more than 24 hours, and no presence of cochlear symptoms and other neurological symptoms and signs. To accurately diagnose vestibular neuritis, various diagnostic tests such as the head impulse test, bithermal caloric test, and vestibular-evoked myogenic potential test are conducted. Various treatments for vestibular neuritis have been reported, which are largely divided into symptomatic therapy, specific drug therapy, and vestibular rehabilitation therapy. Symptomatic therapies include generalized supportive care and administration of vestibular suppressants and antiemetics. Specific drug therapies include steroid therapy, antiviral therapy, and vasodilator therapy. Vestibular rehabilitation therapies include generalized vestibular and customized vestibular exercises.

Keyword

Diagnosis; Treatment; Vertigo; Vestibular neuritis

Figure

• 

  Fig. 1. Diagnostic evaluation and treatment of vestibular neuritis. (A) Characteristic clinical features of vestibular neuritis include acute spontaneous vertigo and no presence of cochlear symptoms and other neurological symptoms and signs. Horizontal-torsional spontaneous nystagmus is observed with canal paresis on the affected side. (B) Various treatments of vestibular neuritis include symptomatic therapy, specific drug therapy, and vestibular rehabilitation therapy. −, negative; +, positive.

Reference

References

1. Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the International Classification of Vestibular Disorders. Neurol Clin. 2015; 33:541–50.

2. Strupp M, Mandalà M, López-Escámez JA. Peripheral vestibular disorders: an update. Curr Opin Neurol. 2019; 32:165–73.

3. von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D, et al. Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res. 2015; 25:105–17.

4. Tabet P, Saliba I. Meniere’s disease and vestibular migraine: updates and review of the literature. J Clin Med Res. 2017; 9:733–44.

5. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, et al. Diagnostic criteria for Menière’s disease. J Vestib Res. 2015; 25:1–7.

6. Whitman GT. Dizziness. Am J Med. 2018; 131:1431–7.

7. Brandt T. Vestibular neuritis. In : Brandt T, editor. Vertigo: its multisensory syndrome. 2nd ed. London: Springer-Verlag;2003. p. 67–81.

8. Nylén CO. Some cases of ocular nystagmus due to certain positions of the head. Acta Otolaryngol (Stockholm). 1924; 6:106–37.

9. Lumio JS, Aho J. Vestibular neuronitis. Ann Otol Rhinol Laryngol. 1965; 74:264–70.

10. Strupp M, Magnusson M. Acute unilateral vestibulopathy. Neurol Clin. 2015; 33:669–85.

11. Adamec I, Krbot Skorić M, Handžić J, Habek M. Incidence, seasonality and comorbidity in vestibular neuritis. Neurol Sci. 2015; 36:91–5.

12. Strupp M, Brandt T. Vestibular neuritis. In : Bronstein AM, editor. Oxford textbook of vertigo and imbalance. Oxford: Oxford University Press;2013. p. 207–16.

13. Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol. 2007; 20:40–6.

14. Wiener-Vacher SR, Quarez J, Priol AL. Epidemiology of vestibular impairments in a pediatric population. Semin Hear. 2018; 39:229–42.

15. Hülse R, Biesdorf A, Hörmann K, Stuck B, Erhart M, Hülse M, et al. Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals. Otol Neurotol. 2019; 40:88–95.

16. Greco A, Macri GF, Gallo A, Fusconi M, De Virgilio A, Pagliuca G, et al. Is vestibular neuritis an immune related vestibular neuropathy inducing vertigo? J Immunol Res. 2014; 2014:459048.

17. Jeong SH, Kim HJ, Kim JS. Vestibular neuritis. Semin Neurol. 2013; 33:185–94.

18. Le TN, Westerberg BD, Lea J. Vestibular neuritis: recent advances in etiology, diagnostic evaluation, and treatment. Adv Otorhinolaryngol. 2019; 82:87–92.

19. Kim JS. When the room is spinning: experience of vestibular neuritis by a neurotologist. Front Neurol. 2020; 11:157.

20. Shikino K, Ikusaka M. Alexander’s law in vestibular neuritis. BMJ Case Rep. 2021; 14:e239705.

21. Halmagyi GM, Gresty MA, Gibson WP. Ocular tilt reaction with peripheral vestibular lesion. Ann Neurol. 1979; 6:80–3.

22. Choi KD, Oh SY, Kim JS. Head thrust test. Ann Clin Neurophysiol. 2006; 8:1–5.

23. Kattah JC. Use of HINTS in the acute vestibular syndrome. An overview. Stroke Vasc Neurol. 2018; 3:190–6.

24. Lee YJ, Shin JE, Park MS, Kim JM, Na BR, Kim CH, et al. Comprehensive analysis of head-shaking nystagmus in patients with vestibular neuritis. Audiol Neurootol. 2012; 17:228–34.

25. Hain TC, Fetter M, Zee DS. Head-shaking nystagmus in patients with unilateral peripheral vestibular lesions. Am J Otolaryngol. 1987; 8:36–47.

26. Sharpe JA. Neurophysiology and neuroanatomy of smooth pursuit: lesion studies. Brain Cogn. 2008; 68:241–54.

27. Han SB, Yang HK, Hyon JY, Seo JM, Lee JH, Lee IB, et al. Efficacy of a computerized optokinetic nystagmus test in prediction of visual acuity of better than 20/200. Invest Ophthalmol Vis Sci. 2011; 52:7492–7.

28. Choi YS, Na HG, Song SY, Kim YD, Bae CH. Clinical significance of saccade test, smooth pursuit test, and optokinetic nystagmus test in nystagmography. Yeungnam Univ J Med. 2017; 34:29–36.

29. Min KK, Ha JS, Kim MJ, Cho CH, Cha HE, Lee JH. Clinical use of subjective visual horizontal and vertical in patients of unilateral vestibular neuritis. Otol Neurotol. 2007; 28:520–5.

30. Okinaka Y, Sekitani T, Okazaki H, Miura M, Tahara T. Progress of caloric response of vestibular neuronitis. Acta Otolaryngol Suppl. 1993; 503:18–22.

31. Rosengren SM, Colebatch JG, Young AS, Govender S, Welgampola MS. Vestibular evoked myogenic potentials in practice: methods, pitfalls and clinical applications. Clin Neurophysiol Pract. 2019; 4:47–68.

32. Shim DB, Song MH, Park HJ. Typical sensory organization test findings and clinical implication in acute vestibular neuritis. Auris Nasus Larynx. 2018; 45:916–21.

33. Hong HR, Shim DB, Kim TS, Shim BS, Ahn JH, Chung JW, et al. Results of caloric and sensory organization testing of dynamic posturography in migrainous vertigo: comparison with Meniere’s disease and vestibular neuritis. Acta Otolaryngol. 2013; 133:1236–41.

34. Ahmed MF, Goebel JA, Sinks BC. Caloric test versus rotational sinusoidal harmonic acceleration and step-velocity tests in patients with and without suspected peripheral vestibulopathy. Otol Neurotol. 2009; 30:800–5.

35. Hamid MA. Clinical value of sinusoidal harmonic acceleration test results. Site of lesion and side of lesion. Neurol Clin. 1990; 8:287–95.

36. Karlberg M, Annertz M, Magnusson M. Acute vestibular neuritis visualized by 3-T magnetic resonance imaging with high-dose gadolinium. Arch Otolaryngol Head Neck Surg. 2004; 130:229–32.

37. Linstrom CJ. Office management of the dizzy patient. Otolaryngol Clin North Am. 1992; 25:745–80.

38. Baloh RW. Clinical practice. Vestibular neuritis. N Engl J Med. 2003; 348:1027–32.

39. Ariyasu L, Byl FM, Sprague MS, Adour KK. The beneficial effect of methylprednisolone in acute vestibular vertigo. Arch Otolaryngol Head Neck Surg. 1990; 116:700–3.

40. Sjögren J, Magnusson M, Tjernström F, Karlberg M. Steroids for acute vestibular neuronitis-the earlier the treatment, the better the outcome? Otol Neurotol. 2019; 40:372–4.

41. Shupak A, Issa A, Golz A, Margalit Kaminer, Braverman I. Prednisone treatment for vestibular neuritis. Otol Neurotol. 2008; 29:368–74.

42. Goudakos JK, Markou KD, Psillas G, Vital V, Tsaligopoulos M. Corticosteroids and vestibular exercises in vestibular neuritis. Single-blind randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2014; 140:434–40.

43. Strupp M, Zingler VC, Arbusow V, Niklas D, Maag KP, Dieterich M, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004; 351:354–61.

44. Ramos Alcocer R, Ledezma Rodríguez JG, Navas Romero A, Cardenas Nuñez JL, Rodríguez Montoya V, Deschamps JJ, et al. Use of betahistine in the treatment of peripheral vertigo. Acta Otolaryngol. 2015; 135:1205–11.

45. Lacour M, Helmchen C, Vidal PP. Vestibular compensation: the neuro-otologist’s best friend. J Neurol. 2016; 263(Suppl 1):S54–64.

46. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015; 1:CD005397.

47. Heskin-Sweezie R, Titley HK, Baizer JS, Broussard DM. Type B GABA receptors contribute to the restoration of balance during vestibular compensation in mice. Neuroscience. 2010; 169:302–14.

48. Igarashi M. Vestibular compensation. An overview. Acta Otolaryngol Suppl. 1984; 406:78–82.

49. Rossi-Izquierdo M, Santos-Pérez S, Soto-Varela A. What is the most effective vestibular rehabilitation technique in patients with unilateral peripheral vestibular disorders? Eur Arch Otorhinolaryngol. 2011; 268:1569–74.

50. Hillier S, McDonnell M. Is vestibular rehabilitation effective in improving dizziness and function after unilateral peripheral vestibular hypofunction? An abridged version of a Cochrane Review. Eur J Phys Rehabil Med. 2016; 52:541–56.

51. Han BI, Song HS, Kim JS. Vestibular rehabilitation therapy: review of indications, mechanisms, and key exercises. J Clin Neurol. 2011; 7:184–96.

52. Eleftheriadou A, Skalidi N, Velegrakis GA. Vestibular rehabilitation strategies and factors that affect the outcome. Eur Arch Otorhinolaryngol. 2012; 269:2309–16.